Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Case Reports

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Division of Hematology/Oncology, Sanford Cancer Center, Sioux Falls, SD USA
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester
Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester
Haematologica Early view Sep 14, 2023 https://doi.org/10.3324/haematol.2023.283740

Abstract

Not available.

Figures & Tables

Article Information

Early view : Case Reports
 
DOI
https://doi.org/10.3324/haematol.2023.283740
Pubmed
37706335
 
Published
2023-09-14
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2023 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
268
PDF Downloads
111

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2023 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online